UK markets close in 1 hour 16 minutes

Nitto Denko Corporation (NDEKF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
76.350.00 (0.00%)
As of 11:54AM EDT. Market open.
Full screen
Loading interactive chart…
  • Business Wire

    Nitto Strengthens Oligonucleotide Therapeutic Manufacturing Business

    In response to the rapid market expansion of oligonucleotide therapeutics that have potential to treat both common and intractable diseases, Nitto Denko Corporation (Headquarters: Osaka; President: Hideo Takasaki; referred to hereafter as "Nitto") will invest approximately 25 billion Japanese yen in Nitto Denko Avecia Inc. (Headquarters: Massachusetts, USA; referred to hereafter as "Avecia"), a subsidiary of Nitto, and other related business establishments and group companies. This investment will significantly increase the manufacturing capacity of its oligonucleotide therapeutic business.